Transform legacy spreadsheets into maintainable, automated tools that scale and survive the test of time.

Mayor Zohran Mamdani’s drive to expand “free” (city-run, taxpayer-funded) preschool programs is already squeezing private-sector providers, suggesting this “transformation” is more about a government ...

The drumbeat for the diminishing prospects of the first-run syndication business has been growing louder over the past few years amid a shrinking marketplace. Now, NBCUniversal has become the first ...

State lawmakers might reduce funding for Running Start, a program that lets high school juniors and seniors take courses and earn credits at community and technical colleges. Running Start students ...

CHARLESTON — A nonprofit run by City Councilman Aaron Polkey, who was sworn in last month, is set to receive nearly $240,000 from the city for a homeless program. Polkey, president and CEO of Palmetto ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

In case you've faced some hurdles solving the clue, Software program run through a browser, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy ...

Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...

Current school board member Rae Gallagher said she hopes to continue preserving protections and programs for students in her reelection run for the Frederick County Board of Education. She said she ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.